Breast Cancer During Pregnancy: Epidemiology, Surgical Treatment, and Staging

  • Oreste Gentilini
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 178)

Abstract

Historically, pregnancy-associated breast cancer was defined as breast cancer diagnosed during pregnancy and within 1 year of delivery. The present chapter deals with the situation of coincident breast cancer and pregnancy, which represents the real challenge for physicians. In fact, breast cancer diagnosed during lactation does not pose specific therapeutic problems compared to all other breast cancer and therefore is not discussed here. Moreover, the term “pregnancy-associated” somehow implies that cancer might be induced or stimulated by the presence of pregnancy, while it seems more a coincidence rather than an association. From this standpoint, we think that it might be more appropriate to define this clinical scenario simply as breast cancer during pregnancy (BCdP).

Keywords

Breast Cancer Sentinel Lymph Node Biopsy Radiat Oncol Biol Phys Pregnant Patient Breast Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berry DL, Theriault RL, Holmes FA et al. (1999) Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17: 855–861PubMedGoogle Scholar
  2. 2.
    Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, Lejeune C, Martin PM, Piana L (1997) Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72(5): 720–727PubMedCrossRefGoogle Scholar
  3. 3.
    Cardonick E, Iacubucci A (2004) Use of chemotherapy during pregnancy. Lancet Oncol 5: 283–291PubMedCrossRefGoogle Scholar
  4. 4.
    Duncan PG, Pope WDB, Cohen MM et al. (1986) Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 64: 790–794PubMedCrossRefGoogle Scholar
  5. 5.
    Garel C, Brisse H, Sebag G et al. (1998) Magnetic resonance imaging of the foetus. Pediatr Radiol 28: 201–211PubMedCrossRefGoogle Scholar
  6. 6.
    Gentilini O, Cremonesi M, Trifirò G et al. (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15: 1348–1351PubMedCrossRefGoogle Scholar
  7. 7.
    Gentilini O, Masullo M, Rotmensz N et al. (2005) Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. EJSO 31: 232–236PubMedCrossRefGoogle Scholar
  8. 8.
    Halakivi-Clarke L, Cho E, Onojafe I, Liao DJ, Clarke R (2000) Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clin Cancer Res 6: 305–308.PubMedGoogle Scholar
  9. 9.
    Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation and its impact on survival. Int J Radiat Oncol Biol Phys 65(5): 1353–1360PubMedCrossRefGoogle Scholar
  10. 10.
    International Commission on Radiological Protection (2003) Biological effects after prenatal irradiation (embryo and foetus). ICRP publication 90. Ann ICRP 33(1–2): 5–206Google Scholar
  11. 11.
    Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, Simozuma K, Enomoto K, Fujiwara K, Nanasawa T et al. (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 83(11): 1143–1149PubMedGoogle Scholar
  12. 12.
    Johansson O, Loman N, Borg A et al. (1998) Pregnancy-associated breast cancer in BRCA1 and BRCA2 germ-line mutation carriers. Lancet 352: 1359–1360CrossRefGoogle Scholar
  13. 13.
    Kal HB, Struikmans H (2005) Radiotherapy during pregnancy: fact and fiction. Lancet Oncol6: 328–333Google Scholar
  14. 14.
    Keleher A, Wendt III R, Delpassand E, Stachowiak AM, Kuerer HM (2004) The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 10: 492–495PubMedCrossRefGoogle Scholar
  15. 15.
    Kuerer H, Gwyn K, Ames F et al. (2002) Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131: 108–110PubMedCrossRefGoogle Scholar
  16. 16.
    Lyman GH, Giuliano AE, Somerfield MR et al. (2005) American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer J Clin Oncol 23: 7703–7720Google Scholar
  17. 17.
    Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A (2003) Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98(5): 1055–1060PubMedCrossRefGoogle Scholar
  18. 18.
    Mitre B, Kaubour A, Mauser N (1997) Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol 41: 1121–1130PubMedGoogle Scholar
  19. 19.
    Moore HCF, Foster RS (2000) Breast cancer and pregnancy. Semin Oncol 27: 646–653PubMedGoogle Scholar
  20. 20.
    Nicklas A, Baker M (2000) Imaging strategies in pregnant cancer patients. Semin Oncol;27: 623–632Google Scholar
  21. 21.
    Pavlidis NA, Pentheroudakis G (2005) The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 31(6): 439–447PubMedCrossRefGoogle Scholar
  22. 22.
    Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42: 126–140PubMedCrossRefGoogle Scholar
  23. 23.
    Schwartz GF, Giuliano AE, Veronesi U (2002) Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 94(10): 2542–2551PubMedCrossRefGoogle Scholar
  24. 24.
    Schwartz GF, Veronesi U, Clough K et al. (2006) Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy Cancer 107(2): 242–250Google Scholar
  25. 25.
    Shannon J, Douglas-Jones AG, Dallimore NS (2001) Conversion to core-biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol 54: 762–765PubMedGoogle Scholar
  26. 26.
    Vujovic O, Cherian A, Dar AR, Stitt L, Perera F (2006) Eleven-year follow up results in the delay of breast irradiation after conservative surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys 64(3): 760–764PubMedCrossRefGoogle Scholar
  27. 27.
    Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138: 91–99PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Oreste Gentilini
    • 1
  1. 1.Breast SurgeryEuropean Institute of OncologyMilanItaly

Personalised recommendations